Japan Ahead: Olympus COO Abia on Strategy, Outlook

The transcript discusses Olympus' strategic shift towards medical devices, divestment of its science business, and focus on mergers and acquisitions in therapeutics. It outlines financial goals, product innovation, and governance reforms post-scandal. The challenges of globalization and economic growth in Japan are addressed, along with supply chain issues and market adaptation strategies.

Why did Olympus decide to focus on medical devices instead of cameras?

• The camera market was declining due to smartphones.

• Medical devices are more profitable.

• Cameras were banned in some countries.

• Medical devices are easier to manufacture.

What is the main reason for Olympus considering the sale of its scientific solutions division?

• To enter the smartphone market.

• To reduce company size.

• To invest in new camera technology.

• To focus on the healthcare sector.

What strategy is Olympus using to fill gaps in its medical portfolio?

• Increasing organic growth.

• Reducing product lines.

• Expanding into new markets.

• Mergers and acquisitions.

What operating margin does Olympus aim to achieve by fiscal 2023?

• 30%

• 25%

• 20%

• 15%

What is a key focus of Olympus's product pipeline?

• Reducing costs.

• Elevating standard care.

• Expanding camera features.

• Entering the smartphone market.

How has Olympus improved its governance since the accounting scandal?

• By reducing board size.

• By enhancing corporate governance.

• By increasing marketing efforts.

• By focusing on camera technology.

What challenge has Olympus faced due to the weak Japanese yen?

• Increased production costs.

• Improved profitability in the US.

• Higher import taxes.

• Decreased global sales.